These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7700068)

  • 1. Treatment perspectives in hypertension.
    Zanchetti A
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S57-60. PubMed ID: 7700068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular consequences of hypertension: therapeutic effects on organ damage and on cardiovascular events.
    Zanchetti A
    Blood Press Suppl; 1994; 1():1-4. PubMed ID: 8205291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Has antihypertensive treatment prevented vascular disease or vascular events?
    Zanchetti A
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S1-5. PubMed ID: 1376826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypertension and cardiovascular damage].
    Zanchetti A
    Ann Ital Med Int; 1992; 7(3 Suppl):97S-99S. PubMed ID: 1297404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
    Leenen FH
    Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit.
    Gueyffier F; Froment A; Gouton M
    J Hum Hypertens; 1996 Jan; 10(1):1-8. PubMed ID: 8642184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New goals in hypertension management: target-organ protection beyond blood pressure lowering].
    Safar ME; Struijker-Boudier HA
    Drugs; 2003; 63 Spec No 1():45-7. PubMed ID: 12708882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient.
    Ong HT
    QJM; 2005 Aug; 98(8):599-614. PubMed ID: 16006501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large therapeutic studies in elderly patients with hypertension.
    Orozco-Valero M
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S38-43. PubMed ID: 11986892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure and coronary heart disease: a review of the evidence.
    Lawes CM; Bennett DA; Lewington S; Rodgers A
    Semin Vasc Med; 2002 Nov; 2(4):355-68. PubMed ID: 16222626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk.
    Hemmelgarn BR; Zarnke KB; Campbell NR; Feldman RD; McKay DW; McAlister FA; Khan N; Schiffrin EL; Myers MG; Bolli P; Honos G; Lebel M; Levine M; Padwal R;
    Can J Cardiol; 2004 Jan; 20(1):31-40. PubMed ID: 14968141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New therapeutic outlooks in the treatment of the hypertensive patient].
    Ambrosioni E; Bacchelli S; Borghi C
    Ann Ital Med Int; 1995 Oct; 10 Suppl():78S-81S. PubMed ID: 8562273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.